Pramipexole TCI P2879

Pramipexole from TCI is an aminobenzothiazole derivative known in pharmacology as a dopamine receptor agonist, acting mainly at the D2 and D3 subtypes. It belongs to the category of pharmaceutical research reagents for experimental use and is not intended for human or veterinary treatment. In the laboratory, pramipexole serves as a reference compound in neuropharmacology research and dopamine receptor studies. It is also used in developing and validating pharmaceutical analytical methods that need a comparison material with a well-defined structure.

Researchers choose pramipexole because its pharmacological profile has been widely studied in the scientific literature. This makes it a good positive control or comparator when screening new compounds that target the dopaminergic system. Its structure has a tetrahydrobenzothiazole ring that carries an amino group and a propylamino chain, plus a single chiral centre that determines its activity. These structural features also make it useful in analytical chemistry, for example in enantiomer separation, stability testing, and identifying degradation products during formulation studies.

In Indonesia, this material is relevant to pharmacology laboratories, pharmaceutical analysis groups, and neuroscience research teams at universities and research institutions. Academic laboratories can use it as a well-documented reference substance in receptor pharmacology teaching and research projects. Analytical laboratories working on pharmaceutical method development can use it to build and check separation and detection methods. Formulation researchers can use it in stability and degradation studies that need a structurally clear comparison compound.

• Dopamine receptor studies: pramipexole is a known agonist at the D2 and D3 subtypes, so it works as a reliable reference ligand when characterising dopaminergic receptor activity in experimental systems.
• Neuropharmacology research: its pharmacological profile is well described in the literature, so researchers can use it as a positive control when testing new compounds aimed at the dopaminergic system.
• Analytical method development and validation: it has a clearly defined aminobenzothiazole structure, which makes it a suitable comparison material for developing and verifying pharmaceutical analytical procedures.
• Enantiomer separation studies: the molecule has a single chiral centre that determines its activity, so it is a relevant model compound for developing and evaluating chiral separation methods.
• Stability testing and degradation product identification: its tetrahydrobenzothiazole ring and amine groups make it a useful subject for formulation studies that track stability and identify degradation products.

Store pramipexole in its original, tightly closed manufacturer's container. Keep it in a dry, well-ventilated place away from direct light, heat sources, and incompatible materials, and follow the specific storage conditions on the TCI label and Safety Data Sheet. Make sure the container is clearly labelled and kept in a reagent storage area with access limited to trained staff. Because this is a pharmacologically active compound, handle it only in a laboratory setting. Wear gloves, safety glasses, and a lab coat, and avoid creating or breathing in dust. Weigh it in a fume hood or ventilated enclosure where possible. Wash your hands after handling, and dispose of waste according to institutional and local regulations. This product is for experimental research use only and must not be used for human or veterinary treatment.

—